MDT

89.97

+0.71%↑

VEEV

275.84

-1.9%↓

A

123.3

-0.67%↓

WBA

11.51

-0.35%↓

HQY

94.45

-2.78%↓

MDT

89.97

+0.71%↑

VEEV

275.84

-1.9%↓

A

123.3

-0.67%↓

WBA

11.51

-0.35%↓

HQY

94.45

-2.78%↓

MDT

89.97

+0.71%↑

VEEV

275.84

-1.9%↓

A

123.3

-0.67%↓

WBA

11.51

-0.35%↓

HQY

94.45

-2.78%↓

MDT

89.97

+0.71%↑

VEEV

275.84

-1.9%↓

A

123.3

-0.67%↓

WBA

11.51

-0.35%↓

HQY

94.45

-2.78%↓

MDT

89.97

+0.71%↑

VEEV

275.84

-1.9%↓

A

123.3

-0.67%↓

WBA

11.51

-0.35%↓

HQY

94.45

-2.78%↓

Search

Durect Corp

Closed

0.6 -1.64

Overview

Share price change

24h

Current

Min

0.54

Max

0.61

Key metrics

By Trading Economics

Employees

20

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+329.69% upside

Dividends

By Dow Jones

Next Earnings

12 Aug 2025

Market Stats

By TradingEconomics

Market Cap

-1.8M

18M

Previous open

2.24

Previous close

0.6

Durect Corp Chart

Past performance is not a reliable indicator of future results.

Related News

11 Jul 2025, 22:19 UTC

Acquisitions, Mergers, Takeovers

FCC Approves U.S. Cellular Sale to T-Mobile

11 Jul 2025, 17:28 UTC

Major Market Movers

SharpLink Gaming Gains on Ethereum Purchase

11 Jul 2025, 16:57 UTC

Earnings

BASF Cuts Outlook on Global Economy Uncertainty

11 Jul 2025, 21:45 UTC

Market Talk

Fitch Affirms Germany's Rating, Sees Deficit, Debt Rising -- Market Talk

11 Jul 2025, 19:46 UTC

Acquisitions, Mergers, Takeovers

Kraft Heinz Might Split Up, Report Says. What Investors Need to Know. -- Barrons.com

11 Jul 2025, 19:45 UTC

Market Talk

Crude Futures Post Back-to-Back Weekly Gains -- Market Talk

11 Jul 2025, 19:05 UTC

Market Talk

U.S. Natural Gas Futures Post Third Straight Weekly Loss -- Market Talk

11 Jul 2025, 18:18 UTC

Market Talk

Canada Officials Tight-Lipped on Next Steps in Trump Trade Talks -- Market Talk

11 Jul 2025, 17:35 UTC

Market Talk

Canada Should Target Lower Sectoral Tariffs, Import Quotas in US Trade Talks -- Market Talk

11 Jul 2025, 17:26 UTC

Market Talk

U.S. Oil Rig Count Down by 1 to 424 -- Market Talk

11 Jul 2025, 16:53 UTC

Market Talk

Crude Futures Add to Early Gains -- Market Talk

11 Jul 2025, 16:42 UTC

Earnings

BASF Cuts Outlook on Global Economic Uncertainty

11 Jul 2025, 16:08 UTC

Market Talk

Rise in Canadian Staycations May Help Explain Labor Market Strength -- Market Talk

11 Jul 2025, 16:05 UTC

Earnings

BASF Will Publish Half-Year Results on July 30

11 Jul 2025, 16:04 UTC

Market Talk

Global Equities Roundup: Market Talk

11 Jul 2025, 16:04 UTC

Market Talk

Senior Housing Shortage Gives REITs Pricing Power -- Market Talk

11 Jul 2025, 16:03 UTC

Earnings

BASF: Guidance Cut Is Due to Ongoing Macroeconomic, Geopolitical Uncertainties

11 Jul 2025, 16:02 UTC

Earnings

BASF Continues to Expect Free Cash Flow Between EUR400M and EUR800M in 2025

11 Jul 2025, 16:01 UTC

Earnings

BASF Had Seen Ebitda Before Special Items Between EUR8B and EUR8.4B in 2025

11 Jul 2025, 16:00 UTC

Earnings

BASF Now Sees Ebitda Before Special Items Between EUR7.3B and EUR7.7B in 2025

11 Jul 2025, 15:59 UTC

Earnings

BASF Cuts 2025 Earnings View

11 Jul 2025, 15:58 UTC

Earnings

Nvidia's CEO Has Sold a Million Shares. He Has Millions More to Sell. -- Barrons.com

11 Jul 2025, 15:57 UTC

Earnings

BASF 2Q EBIT Before Special Items EUR810M

11 Jul 2025, 15:54 UTC

Earnings

BASF: Analysts Had Expected 2Q Sales of EUR15.80B

11 Jul 2025, 15:54 UTC

Earnings

BASF 2Q Sales Fell 2.1% on Year

11 Jul 2025, 15:53 UTC

Earnings

BASF 2Q Sales EUR15.77B

11 Jul 2025, 15:52 UTC

Earnings

BASF: This Was in Line With Consensus Estimates

11 Jul 2025, 15:52 UTC

Earnings

BASF 2Q Ebitda Before Special Items EUR1.77B

11 Jul 2025, 15:49 UTC

Earnings

BASF Reports Preliminary 2Q Figures, Adjusts 2025 Outlook

11 Jul 2025, 15:41 UTC

Market Talk

Oil, Gas Prices Not Seen Supporting Drilling Boom -- Market Talk

Peer Comparison

Price change

Durect Corp Forecast

Price Target

By TipRanks

329.69% upside

12 Months Forecast

Average 2.75 USD  329.69%

High 5 USD

Low 0.5 USD

Based on 2 Wall Street analysts offering 12 month price targets forDurect Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

1

Buy

1

Hold

0

Sell

Financials

$

About Durect Corp

DURECT Corporation, a biopharmaceutical company, develops medicines based on its epigenetic regulator program. The company's lead product larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. It also offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine over three days in adults; and Methydur to treat attention deficit hyperactivity disorder. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in other countries. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; and Innocoll Pharmaceuticals Limited. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California.